TearLab Corporation (NASDAQ:TEAR) reported Q2 2017 earnings this Afternoon, coming in at ($0.68) per share, beating Wall Street’s estimates of ($0.75) per Share. Revenue for the quarter came in at $7.00 million beating analyst estimates of $6.86 million
Analyst Coverage For TearLab Corporation (NASDAQ:TEAR)
These are 4 Buy Ratings .
The current consensus rating for TearLab Corporation (NASDAQ:TEAR) is Buy (Score: 3.00) with a consensus target price of $5.75 , a potential (164.98% upside)Recent Insider Trading for TearLab Corporation (NASDAQ:TEAR)
- On 3/30/2017 Awm Investment Company, Inc., Major Shareholder, sold 327,674 with an average share price of $3.20 per share and the total transaction amounting to $1,048,556.80.
- On 5/31/2016 Brock Wright, Director, bought 59,686 with an average share price of $0.78 per share and the total transaction amounting to $46,555.08.
- On 5/26/2016 Brock Wright, Director, bought 130,314 with an average share price of $0.76 per share and the total transaction amounting to $99,038.64.
- On 12/4/2014 Elias Vamvakas, CEO, bought 50,000 with an average share price of $2.24 per share and the total transaction amounting to $112,000.00.
- On 11/18/2014 Elias Vamvakas, CEO, bought 31,187 with an average share price of $2.55 per share and the total transaction amounting to $79,526.85.
- On 11/17/2014 Elias Vamvakas, CEO, bought 18,813 with an average share price of $2.55 per share and the total transaction amounting to $47,973.15.
Recent Trading for TearLab Corporation (NASDAQ:TEAR) Shares of TearLab Corporation closed the previous trading session at 2.17 up +0.16 7.96% with 175,377 shares trading hands.